Starling Oncology (NASDAQ: STLN) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Formerly known as The Oncology Institute, Starling Oncology offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With more than 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, Starling Oncology is changing oncology for the better. For more information, visit www.starlingoncology.com
Oncology Physicians: Discover What’s Next at Starling Oncology
Starling Oncology is growing, and we’re looking for exceptional Hematology Oncology Physicians and Fellows who want to be part of what comes next.
Join us for our Virtual Physician Open House on September 16 and learn more about career opportunities across our expanding organization.
September 16
7:00 a.m. to 7:00 p.m. PT
100% Virtual
Drop in anytime. Come and go as your schedule permits.
You’ll hear directly from our CEO and Chief Medical Officer through exclusive video presentations about:
Whether you’re actively considering your next opportunity, completing fellowship, or simply interested in learning more, this is an easy, no pressure way to meet Starling Oncology and explore what we’re building.
Your next chapter in Oncology could start here.
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
